Monday, July 15, 2024
News
NEWS HOME
»
PRN INDIA
Treating COVID with Metformin Reduces Long COVID Rates
  SocialTwist Tell-a-Friend  
   

MINNEAPOLIS, June 9, 2023 /PRNewswire/ -- A new study published in The Lancet Infectious Diseases supported by the Parsemus Foundation  found a 41% reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42% reduction in emergency room visits, hospitalizations, or death among COVID-19 patients who started metformin treatment.

In the COVID-OUT study, researchers from multiple academic institutions tested the effectiveness of three generic medications—metformin, ivermectin and fluvoxamine—in adults who had been diagnosed with COVID-19 within the last three days. The randomized, quadruple-blinded, placebo-controlled clinical trial was the first in the country to study whether these medications could prevent severe outcomes and Long COVID. The trial found that people who took metformin within seven days after the onset of COVID symptoms were 41% less likely to experience Long COVID than those who had placebo—with a 63% reduction if metformin was started within four days.

"The results of this study are important because Long COVID can have a significant impact on people's lives," said Carolyn Bramante, MD, principal investigator and an assistant professor at the University of Minnesota Medical School. "Metformin is an inexpensive, safe and widely available drug, and its use as a preventive measure could have significant public health implications."

The COVID-OUT study found that metformin can reduce the rate of Long COVID in COVID-19 patients.

Previous data suggested that metformin's anti-inflammatory and anti-infectious properties could treat COVID-19 infection. The antiviral effect was confirmed in a recent analysis of the viral load of COVID-OUT study participants, which is currently available as a preprint. Researchers reported a 3.6-fold decrease in the SARS-CoV-2 virus level in people who received metformin instead of placebo.

Three years into the pandemic, more than  6.8 million people worldwide have died of the virus, and countless people still suffer from Long COVID. As the first COVID treatment proven to reduce Long COVID in a randomized controlled trial, metformin is safe, accessible and low-cost. Metformin is also one of the most commonly prescribed medications in the United States and globally, taken by more than 150 million people each year. This new treatment option is especially important for the approximately one in three patients who cannot take Paxlovid (Pfizer's groundbreaking COVID treatment) because of conflicting medications or health conditions.

"Access to affordable COVID treatment is  a global justice issue. We hope the U.S. and other nations update their guidelines to include metformin as a treatment option for people with COVID-19," added Elaine Lissner, founder and trustee of the Parsemus Foundation, a research funder part of the nonprofit coalition funding the trial. "This would be the first universally available treatment, giving more people a tool to combat the disproportionate impact of this disease."

The Parsemus Foundation works to create meaningful improvements in human and animal health and welfare by advancing innovative and neglected medical research. The foundation has supported rigorous clinical studies on the effectiveness of existing medications to treat COVID infection, including enrollment support and bilingual outreach for the University of Minnesota's COVID-OUT trial.  For more information, see https://www.parsemus.org/humanhealth/covid-19/.

Photo - https://mma.prnewswire.com/media/2097274/Parsemus_Metformin_Long_Covid.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/treating-covid-with-metformin-reduces-long-covid-rates-301846902.html

More News by PR Newswire India

/DISREGARD RELEASE: Bybit/

Kushal's Fashion Jewellery Festive Collection, adorned by Tara Sutaria, beautifully combines glamour and elegance

Unilumin Group Signed an Agreement with Saudi Arabia in the Third Belt and Road Forum for International Cooperation

Transport Corporation of India Ltd. (TCI Group) has been recognized as a Maritime Excellence Achiever at GMIS 2023 by The Ministry of Ports, Shipping & Waterways on 19th October 2023

Bitget Introduces 'Futures Quant' With AI Features

Bitget's Q3 Growth: Second-Highest Market Share Surge and Record High for BGB Holders

HarperCollins Publishers India is proud to announce the publication of SPREADING JOY: How Joyalukkas Became the World's Favourite Jeweller by Joy Alukkas with Thomas Scaria and Nidhi Jain

Go Global or Go Home: New Report Reveals Companies Lacking Global Presence Will Lose Growth Opportunities

MOVIN rolls out the second phase of Electric Vehicles in Bengaluru paving the way for greener deliveries in logistics

Motilal Oswal Financial Services Ltd. (MOFSL) launches #CorporateMushaira, an audio-first campaign for the World Investor Week

UBBF 2023 Intelligent IP Network Summit in Dubai an Impressive Success

Placing Them Right: IBS Path to MBA Career Success

HDFC ERGO reiterates its commitment on making health insurance Accessible, Affordable and Convenient with launch of 6 new products and 2 service upgrades

capSpire expands its global footprint with entry into the Singapore market

GTPL Hathway records its highest quarterly revenues from operation

CCTV+: International reporters experience the romance and vitality of Hangzhou, China

STL expands its Enterprise Networking solution portfolio with Estelan

Mantittude: Skincare for Men encourages men to unleash their inner 'Pataka' this Diwali

The 134th Canton Fair Opened with Optimized Structure and Upgraded Scale

MADAME TUSSAUDS SINGAPORE UNVEILS LIFELIKE FIGURE OF CRICKET ICON VIRAT KOHLI AMIDST ICC MEN'S CRICKET WORLD CUP!

Ugreen unveils power solutions and personal data storage at the Gitex Trade Show in United Arab Emirates.

Meridean Overseas Education Consultants Announces Half-Day Leave to Celebrate India vs. Pakistan Cricket Match

Xinhua Silk Road: Huai'an, UNESCO creative city of gastronomy, explores innovative dev. of food industry via premier regional food expo

Xinhua Silk Road: Fengxin County in E. China's Jiangxi celebrates bountiful harvest of kiwifruit

Casio to Release G-SHOCK Watches with Shining Metallic-Colored Dials

UEG Week 2023 : Babies with a low birthweight four times more likely to develop fatty liver disease in later life

CGTN: Diffusion of tea and its culture along the Silk Road

NEOM announces Leyja, its latest sustainable tourism destination

Expand North Star 2023 kicks off in Dubai gathering game-changing start-ups to accelerate on global stage

World Health Summit kicks off in Berlin

Hexaware Technologies announces new office in Dehradun to bolster its global delivery network

Chinese automotive industry has overtaken to supercars

Participants of the Made in Russia business mission to India held more than 150 negotiations with local importers and distributors

Rummy Passion Raises the Bar: Instant Withdrawals Now Available for All Tiers

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
PM Modi pays tributes to K Kamaraj on hi...
SC assures to take a call on listing mon...
DMK leader TKS Elangovan calls Cauvery d...
Chief Secy Radha Raturi attends 9th Gove...
SC to hear PIL seeking to fill vacant De...
'Will review reasons behind it': JDU Spo...
More...    
 
 Top Stories
Akshay Kumar tests negative for COV... 
Disha Salian death case: BJP MLA Ni... 
"AI will play important role in liv... 
"Demand for reservation of Maratha ... 
Assam CM distributes 41 appointment... 
"Can't wait to dance when you becom... 
Karnataka to remain driving force b... 
Home Minister Amit Shah to chair 7t...